The modest beat on both revenue and EPS is positive but largely anticipated after the July 15 pre-announcement. The reaffirmed guidance and stable payor mix remove downside risk, but volume declines in NICU days (-3.2%) and hospital-based services (-2.8%) remain headwinds. Monitor the Q3 call for any shift in volume trends or reimbursement dynamics.
Price Chart
Executive Summary
Pediatrix Medical Group reported Q2 2026 Adjusted EPS of $0.63, beating the $0.59 consensus by 6.8%, on revenue of $487.8M vs $478.0M consensus. The company reaffirmed full-year Adjusted EBITDA guidance of $280M-$300M. Results were in line with the pre-announcement from July 15, which confirmed stable payor mix and reaffirmed guidance, so the beat is modest and already partially priced in.
Key Financial Metrics
Key Facts
- Adjusted EPS of $0.63 beat consensus of $0.59 by 6.8%
- Net revenue of $487.8M beat consensus of $478.0M by 2.1%
- Revenue grew 4.0% YoY, driven by 2.1% from acquisitions and 1.9% same-unit growth
- Same-unit patient volume declined 2.1% YoY, with NICU days down 3.2%
- Full-year 2026 Adjusted EBITDA guidance reaffirmed at $280M-$300M
- Cash from operations was $126.3M in Q2, down from $138.1M in Q2 2025
- Company used $42.7M for share repurchases during the quarter
Financial Impact
Q2 revenue beat consensus by ~$9.8M; EPS beat by $0.04
Risk Factors
- Ongoing same-unit patient volume declines, particularly in NICU days (-3.2%)
- Transformational and restructuring expenses increased to $8.5M from $3.8M YoY
- Operating cash flow declined 8.5% YoY to $126.3M
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-331488 |
| Document: md-20260804.htm | 0001193125-26-331488 |
| Document: 0001193125-26-331488-index-headers.html | 0001193125-26-331488 |
| Document: 0001193125-26-331488-index.html | 0001193125-26-331488 |
| Document: 0001193125-26-331488.txt | 0001193125-26-331488 |
| 8-K Data (Synthetic) | 0001193125-26-331488 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 4, 2026 12w ago | 8-K | $24.71 $26.47 | ▲ +7.12% | ▲ +8.36% | $28.64 (+15.90%) |
Jul 24, 2026 13w ago | 8-K | $26.14 $26.60 | ▲ +1.76% | ▼ −1.54% | $28.64 (+9.56%) |
Jul 15, 2026 14w ago | 8-K | $25.88 $26.50 | ▲ +2.40% | ▲ +0.05% | $28.64 (+10.66%) |
Apr 17, 2026 27w ago | DEFA14A | $23.19 $22.64 | ▼ −2.37% | ▼ −6.57% | $28.64 (+23.50%) |
Mar 27, 2026 30w ago | DEFA14A | $20.50 $23.39 | ▲ +14.10% | ▲ +1.36% | $28.64 (+39.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers